MedPath

Transdiagnostic processes in (comorbid) anxiety disorder(s), post-traumatic stress disorder, obsessive-compulsive disorder and depression (TAPOD)

Conditions
affective disorders
stress-related disorders
10037176
Registration Number
NL-OMON49963
Lead Sponsor
ProPersona (Nijmegen)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
574
Inclusion Criteria

Current (primary) Axis I diagnosis of anxiety (GAD, Social Phobia, Panic
Disorder, Agoraphobia), PTSD or OCD and/or depression (MDD, Persistent
Depressive Disorder) diagnosis (assessed using the Mini-international
Neuropsychiatric Interview)
From age 18 onwards
Fluent in Dutch
Able to give Informed Consent

Exclusion Criteria

Insufficient comprehension of the Dutch language
Physical, cognitive, or intellectual impairments interfering with
participation, such as deafness, blindness, or sensorimotor handicaps
Diagnosis of bipolar disorder, schizophrenia, schizophreniform disorder,
schizoaffective illness
Current psychosis
Drug or alcohol addiction in the past 6 months

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameters at all timepoints across all groups are: the severity<br /><br>of anxiety and depressive symptoms (assessed with the BAI and IDS-SR), RNT and<br /><br>avoidance (assessed with the RRS, PSWQ, MRNT; BFT, CBAS, BEAQ and Manikin<br /><br>task), cognitive control (assessed with the ATQ-short and IST).</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath